CA22617-4 - 0x00000000000035A9

Study Number: CA22617
Group Number: 4
Study Requirement: Healthy Normal Male and Female
Stipend: up to £ 1,059

Study Criteria:

  • Age: 18 - 55
  • BMI: 0 - 0
  • Weight Restriction: minimum weight 0 lbs

Study Information:

  • Indication: This investigational medication is being developed as a vaccine for Chikungunya infection.
  • Route of Administration: Injection intramuscular
  • Blood Draws: 8

Study Schedule:

  • Schedule Type: Return Only
  • Study Length: 7 Returns

Screening Dates:

Event Day Event Date Site
Wednesday Oct 24 2018 Belfast

Doctor Exam Dates:

Event Day Event Date Site
Wednesday Oct 24 2018 Belfast

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Return Saturday Nov 3 2018 7:00AM Saturday Nov 3 2018 2:30PM 1 Belfast
Return Friday Nov 16 2018 8:30AM Friday Nov 16 2018 12:30PM 1 Belfast
Return Saturday Dec 1 2018 7:00AM Saturday Dec 1 2018 2:30PM 1 Belfast
Return Friday Dec 14 2018 8:30AM Friday Dec 14 2018 12:30PM 1 Belfast
Return Saturday Dec 29 2018 8:30AM Saturday Dec 29 2018 1:00PM 1 Belfast
Return Saturday May 4 2019 8:30AM Saturday May 4 2019 12:30PM 1 Belfast
Return Saturday Nov 2 2019 8:30AM Saturday Nov 2 2019 1:00PM 1 Belfast